-
Immuno‐Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD‐L1 Testing May Not Be Enough
PD-L1 testing alone fails to detect patients who may benefit from ICI. Lower PD-L1 thresholds and TML testing should be considered in future clinical trials.
Category: News
-
The American Association for Cancer Research and No Stomach For Cancer Partner to Offer a Gastric Cancer Research Fellowship
Julian Burks, PhD, a postdoctoral research fellow at Georgetown University, has been selected as the first recipient of the AACR-No Stomach For Cancer Gastric Cancer Research Fellowship.
Category: News
-
Genetic Testing Is Important for Both Patients and Family Members
The understanding of genetic mutations, like tumors that are microsatellite instability-high (MSI-H), and the therapies that go along with them is transforming the world of colorectal cancer, according to John Marshall, M.D.
Category: News
-
Woman mistook her stomach symptoms for food poisoning, warns about risk
For two years, 34-year-old Diana Zepeda thought her GI symptoms were caused by stress and diet.
Category: News
-
Dr. John Marshall: Outspoken advocate and expert
On National Doctors’ Day, the Colorectal Cancer Alliance interviewed Dr. John Marshall.
Category: News
-
Young People with GI Complaints Should Be Screened for Colon Cancer
John Marshall, MD, explains that health care providers need to retool their thinking when young people present with GI complaints, and be open to the possibility that these could indicate colon cancer.
Category: News
-
Opdivo Combination Granted Priority Review to Treat Metastatic Colorectal Cancer
The Food and Drug Administration (FDA) granted priority review to the combination use of Opdivo (nivolumab) and Yervoy (ipilimumab) to treat a subgroup of patients with metastatic colorectal cancer.
Category: News
-
The Nurse’s Role in Colon Cancer Screening
Nurses can help coach and push patients and their physicians along to do the steps that are needed to get good screening, says John Marshall, MD.
Category: News
-
Colorectal Cancer Awareness Month: ‘We Have Work to Do’
Colorectal cancer expert John Marshall, M.D., shares his feelings about the month of March, which is Colorectal Cancer Awareness month.
Category: News
-
Colorectal Cancer Alliance-Funded Research among First to Examine Relationship between Colon Microbiota and Colorectal Cancer
National nonprofit Colorectal Cancer Alliance will invest $125,000 in innovative, peer-reviewed research by Georgetown Lombardi Comprehensive Cancer Center’s Benjamin Weinberg, MD, as part of its Chris4Life Research Program, which funds research in young-onset colorectal cancer and other areas.
Category: News